Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 34 clinical trials
None
RegisterNET - A Registry for Neuroendocrine Tumors in the USA

therapies as well as peptide-receptor radionuclide therapy. Survival is linked to early and accurate diagnoses or to the effective detection of disease recurrence and/or treatment failure. One challenge is

neuroendocrine carcinoma
radionuclide therapy
carcinoma
gastroenteropancreatic neuroendocrine tumor
neuroendocrine tumor
  • 47 views
  • 19 Jun, 2021
  • 1 location
None
PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

This is a retrospective study. The analysis includes patients with advanced neuroendocrine cancer (NEN) treated with systemic therapy, because of inoperable primary tumor or/and metastasis, clinical, imaging, biochemical disease progression and no standard method of treatment hormone overproduction symptoms. The data of patients with advanced NEN with histopathological confirmation is …

  • 0 views
  • 24 May, 2021
  • 2 locations
None
imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS

The PROMPT study aims to routinely implement genomic pre-sorting of metastatic castration-resistant prostate cancer (mCRPC) patients for personalized treatment (e.g. immuno-, PARP inhibitors, or platinum-therapy). The investigators hypothesize that, by doing this early in the disease course (before exhausting standard of care options), it will improve treatment planning, patient outcome, …

  • 0 views
  • 15 Feb, 2021
  • 1 location
None
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse endocrine system and spreading throughout the different organs and tissues of the body. Tumor-induced osteomalacia (TIO) , is a rare, serious paraneoplastic syndrome primarily derived from a benign tumor of mesenchymal tissue. NETs and mesenchymal tumors are often insidious and …

conventional imaging
tetraxetan
pet/ct scan
dotatate
positron emission tomography
  • 0 views
  • 19 Feb, 2021
  • 1 location